PK and PD of Albuterol Spiromax® and ProAir® Hydrofluoroalkane in Pediatric Patients With Asthma

Study Title
Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromaxֲ® and ProAirֲ® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma
Teva Identifier
ABS-AS-102
ClinicalTrials.gov Identifier
NCT01844401
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Albuterol Spiromaxֲ® | Drug: ProAirֲ® HFA

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age group
Child
Age Range
4 Years to 11 Years
Trial Duration
04/01/2013 - 10/01/2013
Phase
Phase 1

Study Type

Interventional